Indeterminate (B3) Breast Lesions and the Ongoing Role of Diagnostic Open Biopsy.

Albeit a low 0.66% malignancy upgrade rate in B3 lesions, no statistically significant patient predictive factors were identified. Until predictive factors and further assessment of vacuum-assisted excision (VAE) techniques evolve, DOB remains the standard of care.